> top > docs > PMC:7164862 > annotations

PMC:7164862 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 0-11 Chemical denotes Chloroquine MESH:D002738
4 15-33 Chemical denotes hydroxychloroquine MESH:D006886
5 53-61 Disease denotes COVID-19 MESH:C000657245
17 156-201 Species denotes severe acute respiratory syndrome coronavirus Tax:694009
18 203-211 Species denotes SARS-CoV Tax:694009
19 314-325 Species denotes coronavirus Tax:11118
20 681-687 Species denotes humans Tax:9606
21 96-107 Chemical denotes chloroquine MESH:D002738
22 270-281 Chemical denotes chloroquine MESH:D002738
23 349-360 Chemical denotes chloroquine MESH:D002738
24 543-554 Chemical denotes chloroquine MESH:D002738
25 775-786 Chemical denotes chloroquine MESH:D002738
26 612-621 Disease denotes infection MESH:D007239
27 799-821 Disease denotes coronavirus infections MESH:D018352
35 1029-1040 Chemical denotes chloroquine MESH:D002738
36 1045-1056 Chemical denotes chloroquine MESH:D002738
37 1221-1232 Chemical denotes chloroquine MESH:D002738
38 851-875 Disease denotes coronavirus disease 2019 MESH:C000657245
39 877-885 Disease denotes COVID-19 MESH:C000657245
40 932-941 Disease denotes mortality MESH:D003643
41 1161-1169 Disease denotes COVID-19 MESH:C000657245
73 1596-1643 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
74 1645-1655 Species denotes SARS-CoV-2 Tax:2697049
75 1743-1753 Species denotes SARS-CoV-2 Tax:2697049
76 1782-1788 Species denotes people Tax:9606
77 1881-1891 Species denotes SARS-CoV-2 Tax:2697049
78 2083-2093 Species denotes SARS-CoV-2 Tax:2697049
79 2175-2185 Species denotes SARS-CoV-2 Tax:2697049
80 2412-2420 Species denotes SARS-CoV Tax:694009
81 2559-2567 Species denotes SARS-CoV Tax:694009
82 2684-2690 Species denotes humans Tax:9606
83 3013-3021 Species denotes SARS-CoV Tax:694009
84 1250-1261 Chemical denotes Chloroquine MESH:D002738
85 1996-2007 Chemical denotes chloroquine MESH:D002738
86 2390-2401 Chemical denotes chloroquine MESH:D002738
87 2533-2544 Chemical denotes chloroquine MESH:D002738
88 3050-3068 Chemical denotes hydroxychloroquine MESH:D006886
89 1327-1334 Disease denotes malaria MESH:D008288
90 1474-1494 Disease denotes psychiatric symptoms MESH:D004421
91 1533-1540 Disease denotes malaria MESH:D008288
92 1733-1741 Disease denotes COVID-19 MESH:C000657245
93 1832-1840 Disease denotes COVID-19 MESH:C000657245
94 1946-1955 Disease denotes infection MESH:D007239
95 2051-2060 Disease denotes infection MESH:D007239
96 2274-2283 Disease denotes mortality MESH:D003643
97 2291-2299 Disease denotes COVID-19 MESH:C000657245
98 2366-2373 Disease denotes malaria MESH:D008288
99 2728-2735 Disease denotes malaria MESH:D008288
100 2898-2918 Disease denotes rheumatoid arthritis MESH:D001172
101 3244-3251 Disease denotes malaria MESH:D008288
102 3383-3390 Disease denotes malaria MESH:D008288
103 2588-2590 CellLine denotes E6 CVCL:4582
108 3630-3641 Chemical denotes chloroquine MESH:D002738
109 3645-3663 Chemical denotes hydroxychloroquine MESH:D006886
110 3764-3770 Disease denotes deaths MESH:D003643
111 3786-3794 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 369-382 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T2 2591-2596 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T3 2642-2648 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T4 2928-2934 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 369-382 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 53-61 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 156-189 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T3 203-211 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T4 528-532 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T5 612-621 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T6 811-821 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T7 851-875 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T8 877-885 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 1327-1334 Disease denotes malaria http://purl.obolibrary.org/obo/MONDO_0005136
T10 1533-1540 Disease denotes malaria http://purl.obolibrary.org/obo/MONDO_0005136
T11 1596-1643 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T12 1596-1629 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T13 1645-1653 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T14 1733-1741 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T15 1743-1751 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T16 1832-1840 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T17 1881-1889 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T18 1946-1955 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T19 2051-2060 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T20 2083-2091 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T21 2175-2183 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T22 2291-2299 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T23 2366-2373 Disease denotes malaria http://purl.obolibrary.org/obo/MONDO_0005136
T24 2412-2420 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T25 2559-2567 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T26 2728-2735 Disease denotes malaria http://purl.obolibrary.org/obo/MONDO_0005136
T27 2898-2918 Disease denotes rheumatoid arthritis http://purl.obolibrary.org/obo/MONDO_0008383
T28 2909-2918 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T29 3013-3021 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T30 3244-3251 Disease denotes malaria http://purl.obolibrary.org/obo/MONDO_0005136
T31 3383-3390 Disease denotes malaria http://purl.obolibrary.org/obo/MONDO_0005136
T32 3786-3794 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 137-144 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T2 369-382 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T3 383-391 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T4 507-511 http://purl.obolibrary.org/obo/CLO_0001757 denotes 1 At
T5 572-573 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 681-687 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T7 1265-1266 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T8 1283-1286 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T9 1812-1813 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T10 2436-2437 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T11 2583-2596 http://purl.obolibrary.org/obo/CLO_0051719 denotes Vero E6 cells
T12 2642-2648 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T13 2684-2690 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T14 2739-2740 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T15 2840-2843 http://purl.obolibrary.org/obo/CLO_0001313 denotes 3·6
T16 2928-2934 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T17 3116-3119 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T18 3700-3701 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T19 3774-3775 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 0-11 Chemical denotes Chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T2 15-33 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T3 96-107 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T4 270-281 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T5 349-360 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T6 543-554 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T7 574-578 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T8 775-786 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T9 1029-1040 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T10 1045-1056 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T11 1115-1120 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T12 1221-1232 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T13 1250-1261 Chemical denotes Chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T14 1273-1277 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T15 1462-1469 Chemical denotes retinal http://purl.obolibrary.org/obo/CHEBI_15035
T16 1982-1987 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T17 1996-2007 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T18 2390-2401 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T19 2533-2544 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T20 2700-2704 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T21 3050-3068 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T22 3358-3362 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T23 3630-3641 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T24 3645-3663 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 408-434 http://purl.obolibrary.org/obo/GO_0050728 denotes anti-inflammatory response
T2 413-434 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T3 485-506 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-61 Sentence denotes Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
T2 63-338 Sentence denotes In-vitro studies have shown that chloroquine is effective against several viruses, including severe acute respiratory syndrome coronavirus (SARS-CoV).1 Multiple mechanisms of action have been identified for chloroquine that disrupt the early stage of coronavirus replication.
T3 339-842 Sentence denotes Moreover, chloroquine affects immune system activity by mediating an anti-inflammatory response, which might reduce damage due to the exaggerated inflammatory response.1 At the time of the SARS epidemic, chloroquine was suggested as a drug that could be used to treat this infection.2 However, randomised, double-blind, controlled studies in humans to evaluate its efficacy for this use were not done, and the true clinical efficacy of chloroquine in treating coronavirus infections was not established.
T4 843-1249 Sentence denotes Because coronavirus disease 2019 (COVID-19) is associated with substantial morbidity and mortality,3 and no specific pharmacological treatment that is effective against it is available, chloroquine and chloroquine-related formulations have been tentatively included among drugs for use in limiting the total burden of COVID-19.4, 5 However, no studies have evaluated the use of chloroquine for prophylaxis.
T5 1250-1742 Sentence denotes Chloroquine is a cheap drug that has been used for decades—predominantly for malaria prophylaxis, for which it had excellent results and good safety and tolerability.1 Severe adverse events, which mainly involve retinal and psychiatric symptoms, occur only when doses prescribed for malaria are substantially higher than required.1 Inhibition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication seems essential to reduce the risk of spread and development of COVID-19.
T6 1743-1956 Sentence denotes SARS-CoV-2 is highly contagious.5 Most people who live in areas with a high incidence of COVID-19 are apparently healthy, but they can be SARS-CoV-2 negative and healthy or healthy but with asymptomatic infection.
T7 1957-2300 Sentence denotes In both cases, effective drugs such as chloroquine and its related formulations might prevent infection (ie, in those who are SARS-CoV-2 negative) or the development of severe symptomatic disease (ie, in those who are SARS-CoV-2 positive and asymptomatic or with minor symptoms), substantially reducing morbidity and mortality due to COVID-19.
T8 2301-2480 Sentence denotes The dose used might be the same as that usually administered for malaria treatment given chloroquine inhibited SARS-CoV replication at a 50% effective concentration of 8·8 μmol/L.
T9 2481-2830 Sentence denotes The half-maximal inhibitory concentration (IC50) of chloroquine inhibition of SARS-CoV replication in Vero E6 cells, 8·8 μmol/L, is substantially lower than the plasma concentrations that are reached in humans when the drug is prescribed to treat malaria at a dose of 25 mg/kg over 3 days.1 For long-term prophylaxis, even lower doses could be used.
T10 2831-3363 Sentence denotes Doses of 3·6 mg/kg, similar to those generally prescribed to treat rheumatoid arthritis, lead to plasma concentrations of 1–3 μmol/L—ie, the same concentration range as the IC50 for SARS-CoV inhibition.1 Alternatively, hydroxychloroquine could be used, for which even greater efficacy has been reported in in-vitro studies.5 Prophylaxis could last for the whole duration of an outbreak, and in countries in which malaria is not endemic, there is no risk of negative events associated with the development of resistance to this drug.
T11 3364-3471 Sentence denotes In countries where malaria is endemic, appropriate monitoring of resistance among Plasmodium spp is needed.
T12 3472-3585 Sentence denotes Future studies might better elucidate the most effective schedule of administration and potential adverse events.
T13 3586-3795 Sentence denotes We advocate for studies to evaluate whether chloroquine or hydroxychloroquine prophylaxis should be considered in a country such as Italy, where there are thousands of cases and deaths as a result of COVID-19.
T14 3797-3831 Sentence denotes We declare no competing interests.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 2898-2918 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T1 0-11 CHEBI:3638;DG_10;CHEBI:3638 denotes Chloroquine
T2 15-33 CHEBI:5801;DG_20;CHEBI:5801 denotes hydroxychloroquine
T3 53-61 SP_7 denotes COVID-19
T4 96-107 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T5 137-144 NCBITaxon:10239 denotes viruses
T6 156-168 SP_10 denotes severe acute
T7 169-180 SP_10;UBERON:0001004 denotes respiratory
T8 181-201 SP_10 denotes syndrome coronavirus
T9 203-211 SP_10 denotes SARS-CoV
T10 270-281 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T11 314-325 NCBITaxon:11118 denotes coronavirus
T12 326-337 GO:0006260 denotes replication
T13 349-360 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T14 369-382 UBERON:0002405 denotes immune system
T15 528-532 SP_10 denotes SARS
T16 543-554 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T17 574-578 CHEBI:23888;CHEBI:23888 denotes drug
T18 681-687 NCBITaxon:9606 denotes humans
T19 775-786 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T20 799-810 NCBITaxon:11118 denotes coronavirus
T21 851-862 NCBITaxon:11118 denotes coronavirus
T22 877-885 SP_7 denotes COVID-19
T23 960-975 CHEBI:52217;CHEBI:52217 denotes pharmacological
T24 1029-1040 CHEBI:3638;CHEBI:3638;DG_10 denotes chloroquine
T25 1045-1056 CHEBI:3638;CHEBI:3638;DG_10 denotes chloroquine
T26 1115-1120 CHEBI:23888;CHEBI:23888 denotes drugs
T27 1161-1169 SP_7 denotes COVID-19
T28 1221-1232 CHEBI:3638;CHEBI:3638;DG_10 denotes chloroquine
T29 1250-1261 CHEBI:3638;DG_10;CHEBI:3638 denotes Chloroquine
T30 1273-1277 CHEBI:23888;CHEBI:23888 denotes drug
T31 1462-1469 UBERON:0000966 denotes retinal
T32 1596-1608 SP_7 denotes severe acute
T33 1609-1620 SP_7;UBERON:0001004 denotes respiratory
T34 1621-1643 SP_7 denotes syndrome coronavirus 2
T35 1645-1655 SP_7 denotes SARS-CoV-2
T36 1657-1668 GO:0006260 denotes replication
T37 1733-1741 SP_7 denotes COVID-19
T38 1743-1753 SP_7 denotes SARS-CoV-2
T39 1782-1788 NCBITaxon:9606 denotes people
T40 1832-1840 SP_7 denotes COVID-19
T41 1881-1891 SP_7 denotes SARS-CoV-2
T42 1982-1987 CHEBI:23888;CHEBI:23888 denotes drugs
T43 1996-2007 CHEBI:3638;CHEBI:3638;DG_10 denotes chloroquine
T44 2083-2093 SP_7 denotes SARS-CoV-2
T45 2175-2185 SP_7 denotes SARS-CoV-2
T46 2291-2299 SP_7 denotes COVID-19
T47 2390-2401 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T48 2412-2420 SP_10 denotes SARS-CoV
T49 2421-2432 GO:0006260 denotes replication
T50 2533-2544 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T51 2559-2567 SP_10 denotes SARS-CoV
T52 2568-2579 GO:0006260 denotes replication
T53 2583-2587 CL_6 denotes Vero
T54 2642-2648 UBERON:0001969 denotes plasma
T55 2684-2690 NCBITaxon:9606 denotes humans
T56 2700-2704 CHEBI:23888;CHEBI:23888 denotes drug
T57 2928-2934 UBERON:0001969 denotes plasma
T58 3013-3021 SP_10 denotes SARS-CoV
T59 3050-3068 CHEBI:5801;DG_20;CHEBI:5801 denotes hydroxychloroquine
T60 3358-3362 CHEBI:23888;CHEBI:23888 denotes drug
T61 3630-3641 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T62 3645-3663 CHEBI:5801;DG_20;CHEBI:5801 denotes hydroxychloroquine
T63 3764-3770 GO:0016265 denotes deaths
T64 3786-3794 SP_7 denotes COVID-19
T94834 0-11 CHEBI:3638;DG_10;CHEBI:3638 denotes Chloroquine
T30854 15-33 CHEBI:5801;DG_20;CHEBI:5801 denotes hydroxychloroquine
T19682 53-61 SP_7 denotes COVID-19
T98454 96-107 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T25476 137-144 NCBITaxon:10239 denotes viruses
T35585 156-168 SP_10 denotes severe acute
T99185 169-180 SP_10;UBERON:0001004 denotes respiratory
T79442 181-201 SP_10 denotes syndrome coronavirus
T65667 203-211 SP_10 denotes SARS-CoV
T1801 270-281 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T88121 314-325 NCBITaxon:11118 denotes coronavirus
T96813 326-337 GO:0006260 denotes replication
T9936 349-360 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T13615 369-382 UBERON:0002405 denotes immune system
T96197 528-532 SP_10 denotes SARS
T17697 543-554 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T13009 574-578 CHEBI:23888;CHEBI:23888 denotes drug
T56976 681-687 NCBITaxon:9606 denotes humans
T51915 775-786 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T97546 799-810 NCBITaxon:11118 denotes coronavirus
T13921 851-862 NCBITaxon:11118 denotes coronavirus
T24166 877-885 SP_7 denotes COVID-19
T50979 960-975 CHEBI:52217;CHEBI:52217 denotes pharmacological
T20488 1029-1040 CHEBI:3638;CHEBI:3638;DG_10 denotes chloroquine
T59678 1045-1056 CHEBI:3638;CHEBI:3638;DG_10 denotes chloroquine
T93050 1115-1120 CHEBI:23888;CHEBI:23888 denotes drugs
T32733 1161-1169 SP_7 denotes COVID-19
T36513 1221-1232 CHEBI:3638;CHEBI:3638;DG_10 denotes chloroquine
T54965 1250-1261 CHEBI:3638;DG_10;CHEBI:3638 denotes Chloroquine
T50667 1273-1277 CHEBI:23888;CHEBI:23888 denotes drug
T96010 1462-1469 UBERON:0000966 denotes retinal
T65018 1596-1608 SP_7 denotes severe acute
T19329 1609-1620 SP_7;UBERON:0001004 denotes respiratory
T19796 1621-1643 SP_7 denotes syndrome coronavirus 2
T16587 1645-1655 SP_7 denotes SARS-CoV-2
T13143 1657-1668 GO:0006260 denotes replication
T18905 1733-1741 SP_7 denotes COVID-19
T37024 1743-1753 SP_7 denotes SARS-CoV-2
T98949 1782-1788 NCBITaxon:9606 denotes people
T33100 1832-1840 SP_7 denotes COVID-19
T92605 1881-1891 SP_7 denotes SARS-CoV-2
T21911 1982-1987 CHEBI:23888;CHEBI:23888 denotes drugs
T43631 1996-2007 CHEBI:3638;CHEBI:3638;DG_10 denotes chloroquine
T72889 2083-2093 SP_7 denotes SARS-CoV-2
T29038 2175-2185 SP_7 denotes SARS-CoV-2
T67579 2291-2299 SP_7 denotes COVID-19
T43234 2390-2401 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T19872 2412-2420 SP_10 denotes SARS-CoV
T32767 2421-2432 GO:0006260 denotes replication
T10976 2533-2544 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T85528 2559-2567 SP_10 denotes SARS-CoV
T53974 2568-2579 GO:0006260 denotes replication
T6318 2583-2587 CL_6 denotes Vero
T36294 2642-2648 UBERON:0001969 denotes plasma
T60655 2684-2690 NCBITaxon:9606 denotes humans
T6054 2700-2704 CHEBI:23888;CHEBI:23888 denotes drug
T12809 2928-2934 UBERON:0001969 denotes plasma
T65602 3013-3021 SP_10 denotes SARS-CoV
T90393 3050-3068 CHEBI:5801;DG_20;CHEBI:5801 denotes hydroxychloroquine
T55637 3358-3362 CHEBI:23888;CHEBI:23888 denotes drug
T36224 3630-3641 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T56270 3645-3663 CHEBI:5801;DG_20;CHEBI:5801 denotes hydroxychloroquine
T35489 3764-3770 GO:0016265 denotes deaths
T54730 3786-3794 SP_7 denotes COVID-19